AMGN Setting to Try 52 Week High AgainAfter a price rejection yet again at the 52 week high at the $243.60 range in May, we see a sell off and now the price is being supported at $219.40. It could also be shorts covering that is forming the consolidation. Stock is also oversold, according to the Stoch RSI. This could be a good entry point to go long and test the 52 week resistance again.Longby shu884
AMGNBased on my analysis: 1. AMGN formed a double bottom (May 20-26). 2. Breakout the neckline with a high volume. 3. Stochastic shows an upward price bias. 4. Traders are advised to take profit at the price level of (1) 231.60 USD or (2) 234-236 USD Syeikh Hafiz Stock Market AnalystLongby syeikhhafiz5
$AMGN - High risk high reward$AMGN Massive inverse head and shoulders if you look at the bigger picture. Monster of a biotech company so would consider this a high risk, high reward play especially with options. Its been beaten down after multiple attempts of breaking out. Play it safe: Buy after 244 (confirm IHS breakout) & stop loss @ 240 Take on risk: Limit buy: $237 Limit sell: 260 Stop loss: $224Longby IMF_Trading4
AMGNHeikin Ashi Candlesticks - not yet a green week, but encouraging long tail. 2 std dev. regression channelLongby murphycharts3
Look at this if you are looking for a good SHORT opportunity!Classic DOUBLE TOP pattern! No need to explain!Shortby Moshkelgosha7
AMGN Long based on earnings and technicalsAMGN just beat earning and has strong technical, so I will be going long with a price target of 242.Longby dudeyou86
AMGEN INC (AMGN), AMAZING LEVELS!!!Look at these Levels and how it works! If we just use such places for trading you don't need to make a lot of trades per month. I will post more such ideas with stock instruments if this post will get a lot of likes. Before to trade my ideas make your own analysis. Thanks for your support! by Yuriy_Bishko68
Is it a good time to short Amgen?Amgen has been cosonlidated in this bulish trend for more than two years. The author observed that the buyers were struggling to prop it up even more to a further breakout. AMGN is likely to fall onto the psychologcal line of 210 and a furthr space down to 200.Shortby davidchengjiajun6
AMGN Risk of TopAMGN has a Flat Top Formation that is breaking to the downside during earnings season. Stocks with weaker earnings are under High Frequency Trader triggers to the downside. The weak run up reveals the large lot selling at this level. by MarthaStokesCMT-TechniTrader6
AMGNStrong sellers come into play after making a lower swing high for continuation to downsideShortby simtrader19a5
Amgen Bull Flag: Just What the Doctor Ordered?Biotechnology stocks surged in the fourth quarter thanks to some takeovers and buyers returning to the health-care sector. Amgen is the biggest of all the biotechs with $144 billion of market cap. It's also one of the few big names that's broken out to new highs. (Along with Vertex .) AMGN's been climbing a wall of worry about competition since the summer. The flurry of good news began in June when its AMG 510 cancer compound successfully shrank lung tumors. Then, earnings beat in both July and October as its new biosimilar franchise surprised the naysayers. Now's the first real pullback since breaking out. AMGN's bullish flag may create potential for a continuation move higher, with Friday's low of $236.24 as a level for risk management. The next earnings report is estimated for Jan. 28.Longby TradeStation10
$AMGN | Weekly TF | Breakout Territorytrend is your friend, find good risk to reward set-ups and play the trend USE STOP LOSSES!!!!Longby WafflesDxb4
$AMGN Technical and fundamental Breakout in AmgenEntry level $216 = Target price $237 = Stop loss $209 Bullish technical setup, Fundamentally bullish with superb earnings and the announcement that they have taken a stake in BieGene, the wider the open the vault the better, start spending that cash hoard. P/E ratio 16.36 Yield, 2.75% Company profile Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA. Longby Bullishcharts1125
Farmacéuticas al Alzathe pharmaceuticals are performing well so the market makers are currently buying on this sector, my principal list on this sector are AMGEN, PFIZER and BRISTOL MYERS, i'm waiting to break levels to buyLongby fritzkuri8
Amgen Announces Positive Results From Two Phase 3 BLINCYTO® (bliAMGN: Amgen 2019-09-24 16:00:00 Amgen Announces Positive Results From Two Phase 3 BLINCYTO® (blinatumomab) Studies In Pediatric Patients With Relapsed Acute Lymphoblastic LeukemiaLongby RocketTickers8
AMGEN Inc AMGN stock looks attractive after a strong rallyAMGEN Inc AMGN american stock looks attractive after a strong rally, waiting for a pullback to weekly demand imbalance around $178 to buy the underlying stock. We don't need any fundamental analysis on a stock to take a trading decision but if you are interested, Amgen AMGN has been a laggard. Amgen's slump had to do with the stocks slowing growth outlook combined with the ever present headwinds that the healthcare sector faces heading into an election year.However, Amgen could address its growth slump. That's exactly what management did in August, causing the stock's price to spike. Yet, in the past five weeks Amgen shares have cooled off, giving investors who were previously experiencing fear of missing out the trade, the chance to get into the stock at a discount to recent highs. Where is the place where those investors can plan to buy AMGEN again? Well, if you look at the attached weekly chart technical analysis, the whole movement started at $178 creating a very strong weekly demand level, that's where we can buy AMGEN inc again. Longby AlfonsoMoreno5